200 related articles for article (PubMed ID: 9221520)
21. Axillary masses in a woman with a history of breast cancer: dermatopathic lymphadenopathy.
Rocco N; Della Corte GA; Rispoli C; Sabatino V; Romano F; Altiero M; Sommella MG; Falco G; Compagna R; Amato B; Accurso A
Int J Surg; 2014; 12 Suppl 2():S40-S43. PubMed ID: 25159542
[TBL] [Abstract][Full Text] [Related]
22. Breast imaging case of the day. Intramammary and axillary lymph node metastases from infiltrating lobular carcinoma of the breast.
Cyrlak D; Carpenter PM
Radiographics; 1999 Oct; 19 Spec No():S73-9. PubMed ID: 10517445
[No Abstract] [Full Text] [Related]
23. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
[TBL] [Abstract][Full Text] [Related]
24. Abnormal axillary lymph nodes on negative mammograms: causes other than breast cancer.
Görkem SB; O'Connell AM
Diagn Interv Radiol; 2012; 18(5):473-9. PubMed ID: 22415745
[TBL] [Abstract][Full Text] [Related]
25. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
26. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
27. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
28. Contribution of minute axillary lymph nodes to accurate staging for patients with breast cancer.
Jiang J; He QQ; Yang XH; Liang Y; Fan LJ; Zhang Y; Guo MQ
Chin Med J (Engl); 2007 Oct; 120(20):1762-5. PubMed ID: 18028767
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
30. Axillary lymph nodes in breast cancer: is size related to metastatic involvement?
Obwegeser R; Lorenz K; Hohlagschwandtner M; Czerwenka K; Schneider B; Kubista E
World J Surg; 2000 May; 24(5):546-50. PubMed ID: 10787074
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
32. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
34. Calcifications in metastatic breast carcinoma in axillary lymph nodes.
Helvie MA; Rebner M; Sickles EA; Oberman HA
AJR Am J Roentgenol; 1988 Nov; 151(5):921-2. PubMed ID: 2845762
[No Abstract] [Full Text] [Related]
35. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
36. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer.
Mustonen P; Farin P; Kosunen O
Ann Chir Gynaecol; 1990; 79(1):15-8. PubMed ID: 2192685
[TBL] [Abstract][Full Text] [Related]
37. The clinical importance of axillary lymphadenopathy detected on screening mammography.
Murray ME; Given-Wilson RM
Clin Radiol; 1997 Jun; 52(6):458-61. PubMed ID: 9202590
[TBL] [Abstract][Full Text] [Related]
38. Metastasis of primitive neuroectodermal tumor to the breast.
Kwak JY; Kim EK; You JK; Oh KK; Hong SW; Kim SH
J Clin Ultrasound; 2002; 30(6):374-7. PubMed ID: 12116099
[TBL] [Abstract][Full Text] [Related]
39. [Breast cancer: axillary dissection--or an unnecessary procedure?].
Schäfer P
Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
[TBL] [Abstract][Full Text] [Related]
40. New era in breast cancer. Impact of screening on disease presentation.
Cady B
Surg Oncol Clin N Am; 1997 Apr; 6(2):195-202. PubMed ID: 9103207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
